Stem is trading at $4.29, up +10.00%, after UBS upgraded the stock from Neutral to Buy and set a $7 price target.
- UBS cited expected software growth and the potential for a sustainable earnings turnaround.
- The rebound followed several weak sessions, while broader markets were modestly higher.
- The upgrade was the clearest identified catalyst for the September 25, 2026 rebound; no new company filing or earnings release was found.